English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The discovery of new chemical entities having enhanced bioactivities and improved functionalities to overcome the prevailing antibiotic resistance and emerging diseases has evolved as the one of the most needed research areas in pharmaceutical field. Intensive research has been done on metal-based drugs and as a result, metal complexes of various Schiff bases are acknowledged as a potential area of research in bioinorganic chemistry on account of their promising applicable uses in several fields of science. Schiff base sulfonamides are versatile pharmacophores forming stable metal-based compounds by coordinating with metals of various oxidation states. As therapeutic candidates, they have been actively used in many applications including antifungal, analgesic, anti-inflammatory, antiviral, antitumor, antibacterial and many more. There has been a worldwide risk of drug resistance in the medical field as most of the pathogenic microbes are capable of deactivating drug substances. This review summarizes the research developments that have taken place from 2008 to 2022 on the pharmaceutical activities of Schiff base sulfonamides and their derived metal-based compounds.

A review on ‘sulfonamides’: their chemistry and pharmacological potentials for designing therapeutic drugs in medical science